rs165602
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_021076.4(NEFH):c.2414A>C(p.Glu805Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.155 in 1,613,862 control chromosomes in the GnomAD database, including 20,439 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Uncertain significancein ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E805V) has been classified as Uncertain significance.
Frequency
Consequence
NM_021076.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NEFH | NM_021076.4 | c.2414A>C | p.Glu805Ala | missense_variant | 4/4 | ENST00000310624.7 | |
NEFH | XM_011530200.3 | c.2126A>C | p.Glu709Ala | missense_variant | 5/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NEFH | ENST00000310624.7 | c.2414A>C | p.Glu805Ala | missense_variant | 4/4 | 1 | NM_021076.4 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.145 AC: 21956AN: 151934Hom.: 1784 Cov.: 31
GnomAD3 exomes AF: 0.151 AC: 37943AN: 250792Hom.: 3076 AF XY: 0.154 AC XY: 20874AN XY: 135748
GnomAD4 exome AF: 0.156 AC: 228065AN: 1461810Hom.: 18654 Cov.: 86 AF XY: 0.157 AC XY: 113951AN XY: 727206
GnomAD4 genome ? AF: 0.144 AC: 21967AN: 152052Hom.: 1785 Cov.: 31 AF XY: 0.149 AC XY: 11072AN XY: 74342
ClinVar
Submissions by phenotype
not provided Benign:2Other:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 30, 2021 | - - |
not provided, no classification provided | literature only | Epithelial Biology; Institute of Medical Biology, Singapore | - | - - |
Benign, criteria provided, single submitter | clinical testing | Invitae | Feb 01, 2024 | - - |
Amyotrophic lateral sclerosis type 1 Benign:2
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | Jan 16, 2015 | - - |
Benign, criteria provided, single submitter | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | Sep 21, 2015 | - - |
not specified Benign:1
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Charcot-Marie-Tooth disease axonal type 2CC Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at